Cargando…
Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk
Autores principales: | Behr, Paulo Eduardo Ballvé, Moriguchi, Emilio Hideyuki, Castro, Iran, Bodanese, Luiz Carlos, Dutra, Oscar Pereira, Leães, Paulo Ernesto, Pimentel Filho, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia - SBC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078356/ https://www.ncbi.nlm.nih.gov/pubmed/30110052 http://dx.doi.org/10.5935/abc.20180133 |
Ejemplares similares
-
Back to Basics: PCSK9 as a New Target for the LDL
Receptor
por: Corral, Pablo
Publicado: (2014) -
PCSK9 Inhibitors: Clinical Relevance, Molecular Mechanisms, and
Safety in Clinical Practice
por: Ferrari, Filipe, et al.
Publicado: (2019) -
Bibliometric Indicators of the Zika Outbreak
por: Albuquerque, Priscila C., et al.
Publicado: (2017) -
Thymic Extracellular Matrix in the Thymopoiesis: Just a Supporting?
por: Lins, Marvin Paulo
Publicado: (2022) -
Shifting gears from embryonic to very small embryonic-like stem cells for regenerative medicine
por: Bhartiya, Deepa
Publicado: (2017)